Dana L Day, AUD, CCC-A | |
4004 N 7th St, Phoenix, AZ 85014-4701 | |
(602) 265-9000 | |
(602) 528-1901 |
Full Name | Dana L Day |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 22 Years |
Location | 4004 N 7th St, Phoenix, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114081130 | NPI | - | NPPES |
835837 | Other | AZ | AHCCCS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | DA747 (Arizona) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Arizona Balance And Hearing Associates,llc | 0244222032 | 4 |
News Archive
Patients in advanced states of myocardial insufficiency generally lose their muscle mass and muscle strength. Indeed a fact that until now has negatively impacted the clinical course of the disease and that has resulted in poor prognoses for patients. Such pathological muscle loss impacts the skeletal muscles in particular.
The progressive loss of skeletal muscle during aging, known as sarcopenia, underlies limitations in physical function and mobility, which in turn lead to falls, loss of independence, institutionalization and even death.
Results from a Phase III program evaluating imiquimod 3.75% and 2.5% creams for the treatment of EGW, applied once daily for up to 8 weeks, demonstrated that both were well-tolerated and more efficacious than placebo, according to data presented at the annual Human Papillomavirus Conference in Montreal, July 3 - 8. Investigators found that efficacy was greatest for imiquimod 3.75% with an enhanced safety profile.
A Florida State University College of Medicine researcher has been awarded two separate grants from the National Institutes of Health (NIH) totaling $2.4 million to continue her work in detecting autism in children as young as 18 months.
› Verified 6 days ago
Provider Name | Arizona Balance & Hearing Associates,llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1871615427 PECOS PAC ID: 0244222032 Enrollment ID: O20040401000354 |
News Archive
Patients in advanced states of myocardial insufficiency generally lose their muscle mass and muscle strength. Indeed a fact that until now has negatively impacted the clinical course of the disease and that has resulted in poor prognoses for patients. Such pathological muscle loss impacts the skeletal muscles in particular.
The progressive loss of skeletal muscle during aging, known as sarcopenia, underlies limitations in physical function and mobility, which in turn lead to falls, loss of independence, institutionalization and even death.
Results from a Phase III program evaluating imiquimod 3.75% and 2.5% creams for the treatment of EGW, applied once daily for up to 8 weeks, demonstrated that both were well-tolerated and more efficacious than placebo, according to data presented at the annual Human Papillomavirus Conference in Montreal, July 3 - 8. Investigators found that efficacy was greatest for imiquimod 3.75% with an enhanced safety profile.
A Florida State University College of Medicine researcher has been awarded two separate grants from the National Institutes of Health (NIH) totaling $2.4 million to continue her work in detecting autism in children as young as 18 months.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dana L Day, AUD, CCC-A 4004 N 7th St, Phoenix, AZ 85014-4701 Ph: (602) 265-9000 | Dana L Day, AUD, CCC-A 4004 N 7th St, Phoenix, AZ 85014-4701 Ph: (602) 265-9000 |
News Archive
Patients in advanced states of myocardial insufficiency generally lose their muscle mass and muscle strength. Indeed a fact that until now has negatively impacted the clinical course of the disease and that has resulted in poor prognoses for patients. Such pathological muscle loss impacts the skeletal muscles in particular.
The progressive loss of skeletal muscle during aging, known as sarcopenia, underlies limitations in physical function and mobility, which in turn lead to falls, loss of independence, institutionalization and even death.
Results from a Phase III program evaluating imiquimod 3.75% and 2.5% creams for the treatment of EGW, applied once daily for up to 8 weeks, demonstrated that both were well-tolerated and more efficacious than placebo, according to data presented at the annual Human Papillomavirus Conference in Montreal, July 3 - 8. Investigators found that efficacy was greatest for imiquimod 3.75% with an enhanced safety profile.
A Florida State University College of Medicine researcher has been awarded two separate grants from the National Institutes of Health (NIH) totaling $2.4 million to continue her work in detecting autism in children as young as 18 months.
› Verified 6 days ago
Dr. Kari Lynn Kuner, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1919 E Thomas Rd, Bldg C, Room 2240, Phoenix, AZ 85016 Phone: 602-546-4689 Fax: 602-546-4683 | |
Mrs. Linda Lee Nieb, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4510 N 37th Ave # Ave85019, Phoenix, AZ 85019 Phone: 602-336-2990 | |
Susan R Schmidt, AUD, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4004 N 7th St, Phoenix, AZ 85014 Phone: 602-265-9000 Fax: 602-528-1900 | |
Dr. Sara E Mclaws, AU.D., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2051 W Northern Ave, Suite 200, Phoenix, AZ 85021 Phone: 602-771-5243 Fax: 602-544-1704 | |
Mr. Gaylen L Reese, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 Fax: 602-222-6588 | |
Allison Sayer, Audiologist Medicare: Medicare Enrolled Practice Location: 1920 E Cambridge Ave, Phoenix, AZ 85006 Phone: 602-933-3277 Fax: 602-933-4326 | |
Dr. Ashley Geske, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-0905 |